{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-037118","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2026-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.639515+00:00","generated_at":"2026-05-15T08:10:06.162478+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Solana Q4 net income $325.6M ($4.25 EPS) on $5.2M revenue; $293.7M in SOL holdings","bullets":["Q4 2025 revenue $5.2M (vs $0.2M prior year), driven by $5.1M staking rewards.","Q4 net income $325.6M ($4.25 EPS) vs net loss $3.9M prior year; includes $526.3M derivative gain.","FY 2025 net loss $40.9M ($1.85 loss per share) vs $11.7M loss prior year.","Cash $7.3M, digital assets (SOL) $293.7M at Dec 31, 2025; combined $301M.","Raised $29.9M via ATM in 2025 to buy SOL; repurchased $3.4M stock in 2026 funded by SOL sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-037118","json":"https://secwatch.observer/filing/0001104659-26-037118.json","markdown":"https://secwatch.observer/filing/0001104659-26-037118.md","text":"https://secwatch.observer/filing/0001104659-26-037118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000110465926037118/0001104659-26-037118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000110465926037118/hsdt-20260330x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:10:06.162478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"dd6d385c0f85587934778f67e267b13f43c0ee78","claim":"Solana Co reported financial results for the fiscal quarter and year ended December 31, 2025.","evidence_excerpt":"On March 30, 2026, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000110465926037118/0001104659-26-037118-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and year ended December 31, 2025"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}